Skylight Health Announces Q3 2021 Earnings Conference Call
Skylight Health Group (NASDAQ:SLHG) will release its third-quarter financial results on November 15, 2021, after market close. A conference call is scheduled for November 16, 2021, at 8:00 AM EDT to discuss the results. Additionally, the company will issue 101,738 shares related to its previous acquisition of River City Medical Associates, subject to a four-month hold and TSX-V approval. Skylight aims to improve patient health outcomes through a multi-state primary care network, assisting independent practices in transitioning to value-based care.
- Scheduled release of Q3 financial results on November 15, 2021, indicating transparency.
- Hosting a conference call for stakeholders to discuss earnings, enhancing investor engagement.
- Issuing shares related to an acquisition, reflecting ongoing business growth and expansion efforts.
- None.
TORONTO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (NASDAQ:SLHG; TSXV: SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today announced that its financial results for the third quarter of 2021 will be released after the close of market on November 15, 2021. The Company will host a conference call at 8:00am EDT on the morning of November 16, 2021, to discuss the financial results.
If you would like to participate in the call, details can be found below. Please dial in approximately 10 minutes prior to the start of the call.
Conference Call Details:
| Date: | Tuesday, November 16, 2021 |
| Time: | 8:00 a.m. (ET) |
| US / Canada Toll Free Dial In: | 1-800-319-4610 |
| Toronto Local Dial In: | 1-416-915-3239 |
| International Dial In: | 1-604-638-5340 |
| Call Name: | Skylight Health Group Q3 Earnings Call |
An audio replay of the conference call will be available on www.skylighthealthgroup.com within 24 hours after the live call has ended.
The Company is also announcing the issuance of 101,738 shares which is the final issuance related to its previously announced acquisition of River City Medical Associates announced on February 4, 2021. All issued shares will be subject to a four-month hold from the date of issuance and is subject to TSX-V approval.
About Skylight Health Group
Skylight Health Group (NASDAQ:SLHG;TSXV:SLHG) is a healthcare services and technology company, working to positively impact patient health outcomes. The Company operates a US multi-state primary care health network comprised of physical practices providing a range of services from primary care, sub-specialty, allied health, and laboratory/diagnostic testing. The Company is focused on helping small and independent practices shift from a traditional fee-for-service (FFS) model to value-based care (VBC) through tools including proprietary technology, data analytics and infrastructure. In an FFS model, payors (commercial and government insurers) reimburse on an encounter-based approach. This puts a focus on volume of patients per day. In a VBC model, the providers offer care that is aimed at keeping patients healthy and minimize unnecessary health expenditures that are not proven to maintain the patient’s well-being. This places an emphasis on quality over volume. VBC will lead to improved patient outcomes, reduced cost of delivery and drive stronger financial performance from existing practices.
Forward Looking Statements
This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent our current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this release. Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as "look forward," "believe," "continue," "building," or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by us herein are often discussed in filings we make with the Canadian and United States securities regulators, including the Securities and Exchange Commission, available at: www.sec.gov, and Canadian Securities Administrators, available at www.sedar.com, and on our website, at skylighthealthgroup.com.
For more information, please visit our website or contact:
Investor Relations:
Jackie Kelly
investors@skylighthealthgroup.com
416-301-2949
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
FAQ
What is the date for Skylight Health Group's Q3 earnings release?
When will the conference call for Skylight Health's financial results occur?
What is the stock symbol for Skylight Health Group?
How many shares is Skylight Health Group issuing related to its acquisition?
